Product
Amifampridine Phosphate
1 clinical trial
1 indication
Indication
Spinal Muscular Atrophy Type 3Clinical trial
Long Term Safety Study of Amifampridine Phosphate in Ambulatory Patients With Spinal Muscular Atrophy (SMA) Type 3Status: Terminated, Estimated PCD: 2021-09-13